Which has the lower trailing P/E, MOH or RGEN?

RGEN has the lower trailing P/E: MOH trades at 1027.21 and RGEN at 239.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MOH or RGEN?

Over the past five years, MOH grew revenue faster — MOH at a 13.56% CAGR versus RGEN at 9.08%.

Is MOH or RGEN more profitable?

RGEN runs the higher net margin — MOH at -0.02% versus RGEN at 5.29%.

How have MOH and RGEN total returns compared?

Over the past 10 years, MOH delivered 13.01% and RGEN delivered 20.13% annualized total return. Past performance doesn't predict future results.

Molina Healthcare, Inc. (MOH) vs Repligen Corporation (RGEN)

A side-by-side comparison of Molina Healthcare, Inc. and Repligen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MOH

Molina Healthcare, Inc.

$10.19B

$195.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RGEN

Repligen Corporation

$9.87B

$174.86HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MOH vs RGEN

growth of $100 · dividends reinvested · last 10y

MOH +229.2% (+12.7%/yr)RGEN +528.7% (+20.2%/yr)RGEN compounded faster over this window

MOH RGEN

MOH vs RGEN: by the numbers

•MOH is the larger company ($10.19B vs $9.87B market cap).
•RGEN trades at the lower trailing earnings multiple (239.53 vs 1027.21 P/E), one valuation lens rather than an overall verdict.
•RGEN is profitable (5.29% net margin) while MOH runs a net loss (-0.02%).
•MOH grew revenue faster over the past five years (13.56% vs 9.08% CAGR).

Metrics side by side

Valuation

Metric	MOH	RGEN
P/E ratio	1027.21	239.53
Forward P/E	N/A	84.92
P/S ratio	0.23	12.57
P/B ratio	2.44	4.67
EV / EBITDA	19.73	67.03
FCF yield	2.64%	1.12%

Profitability

Metric	MOH	RGEN
Gross margin	13.07%	51.05%
Operating margin	0.66%	8.32%
Net margin	-0.02%	5.29%
ROE	-0.17%	1.97%
ROIC	3.56%	1.85%

Growth (annualized)

Metric	MOH	RGEN
Revenue CAGR (5Y)	13.56%	9.08%
EPS CAGR (5Y)	-4.78%	-5.26%
FCF CAGR (5Y)	-33.98%	22.49%
Total return CAGR (5Y)	-6.35%	-6.86%

Frequently asked

Which has the lower trailing P/E, MOH or RGEN?: RGEN has the lower trailing P/E: MOH trades at 1027.21 and RGEN at 239.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MOH or RGEN?: Over the past five years, MOH grew revenue faster — MOH at a 13.56% CAGR versus RGEN at 9.08%.
Is MOH or RGEN more profitable?: RGEN runs the higher net margin — MOH at -0.02% versus RGEN at 5.29%.
How have MOH and RGEN total returns compared?: Over the past 10 years, MOH delivered 13.01% and RGEN delivered 20.13% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MOH analysis Full RGEN analysis Interactive comparison tool

Dig into the metrics

Molina Healthcare P/E ratio Repligen P/E ratio Molina Healthcare ROE Repligen ROE Molina Healthcare operating margin Repligen operating margin Molina Healthcare revenue growth Repligen revenue growth Molina Healthcare free cash flow Repligen free cash flow

Molina Healthcare & Repligen appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.